Clinical Trial Update: Long Term Follow-Up Study for rAAV-GAD Treated Subjects

View source ↗

Summary

Long-term follow-up results from subjects treated with rAAV-GAD in a Parkinson's disease trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• rAAV-GAD (recombinant adeno-associated virus-delivered glutamic acid decarboxylase)

Snippet

Sponsor: Neurologix, Inc. | Conditions: Parkinson's Disease | Status: TERMINATED